Abionic

Abionic is a Swiss-based biotech company that specializes in the development of nanotechnology-based rapid diagnostic systems. The company's primary product is the abioSCOPE, a diagnostic platform that uses biosensor technology to provide rapid, on-the-spot testing for a variety of medical conditions.

History[edit | edit source]

Abionic was founded in 2010 by Dr. Nicolas Durand and Dr. Iwan Märki. The company's initial focus was on the development of a rapid diagnostic system for allergies. Over time, the company has expanded its product range to include tests for sepsis and iron deficiency.

abioSCOPE[edit | edit source]

The abioSCOPE is a diagnostic platform that uses a combination of nanotechnology and biosensor technology to provide rapid, on-the-spot testing for a variety of medical conditions. The device is designed to be used in a clinical setting and can provide results in as little as five minutes.

The abioSCOPE uses a disposable microfluidic cartridge to perform the test. The cartridge contains a biosensor that is coated with a specific antigen. When a sample is introduced into the cartridge, any antibodies present in the sample will bind to the antigen on the biosensor. The device then uses a laser to measure the change in the biosensor's optical properties, which allows it to determine the concentration of antibodies in the sample.

Applications[edit | edit source]

The abioSCOPE has a wide range of applications in the field of diagnostics. It can be used to test for a variety of conditions, including allergies, sepsis, and iron deficiency. The device can also be used to monitor patient response to treatment.